2023 Q4 Form 10-K Financial Statement

#000164033423002133 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2023
Revenue $3.950K $49.19K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $5.928K $0.00
YoY Change
% of Gross Profit
Operating Expenses $73.27K $202.5K
YoY Change 101.0% 731.47%
Operating Profit -$69.32K -$153.3K
YoY Change 212.29%
Interest Expense $0.00 $0.00
YoY Change -100.0% -100.0%
% of Operating Profit
Other Income/Expense, Net -$9.258K -$1.869M
YoY Change
Pretax Income -$78.58K -$2.023M
YoY Change 254.0% 8603.25%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$78.58K -$2.023M
YoY Change 254.0% 8603.25%
Net Earnings / Revenue -1989.29% -4112.13%
Basic Earnings Per Share -$3.41
Diluted Earnings Per Share -$0.13
COMMON SHARES
Basic Shares Outstanding 586.7K shares 592.7K shares
Diluted Shares Outstanding 586.7K shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $220.4K $151.7K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $0.00
Prepaid Expenses $28.90K $34.86K
Receivables
Other Receivables
Total Short-Term Assets $480.7K $418.3K
YoY Change 4.84% 24.04%
LONG-TERM ASSETS
Property, Plant & Equipment $973.3K $884.3K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.921M $1.832M
YoY Change 38.21%
TOTAL ASSETS
Total Short-Term Assets $480.7K $418.3K
Total Long-Term Assets $1.921M $1.832M
Total Assets $2.402M $2.250M
YoY Change 29.93% 567.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.979M $3.964M
YoY Change 154.74% 13743.58%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.979M $3.964M
Total Long-Term Liabilities
Total Liabilities $4.194M $3.964M
YoY Change 168.52% 13743.58%
SHAREHOLDERS EQUITY
Retained Earnings -$2.124M -$2.046M
YoY Change 4575.5% 8703.76%
Common Stock $587.00 $331.7K
YoY Change -99.82% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.793M -$1.714M
YoY Change
Total Liabilities & Shareholders Equity $2.402M $2.250M
YoY Change 29.93% 567.28%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2023
OPERATING ACTIVITIES
Net Income -$78.58K -$2.023M
YoY Change 254.0% 8603.25%
Depreciation, Depletion And Amortization $5.928K $0.00
YoY Change
Cash From Operating Activities -$38.05K -$257.3K
YoY Change -1776.86% 2561.2%
INVESTING ACTIVITIES
Capital Expenditures $884.3K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$94.96K -$3.270M
YoY Change -93.41% 896.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $201.7K $3.679M
YoY Change -86.0% 986.19%
NET CHANGE
Cash From Operating Activities -$38.05K -$257.3K
Cash From Investing Activities -$94.96K -$3.270M
Cash From Financing Activities $201.7K $3.679M
Net Change In Cash $68.70K $151.0K
YoY Change 2052.32% 20872.22%
FREE CASH FLOW
Cash From Operating Activities -$38.05K -$257.3K
Capital Expenditures $884.3K
Free Cash Flow -$1.142M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-23238 usd
CY2022Q4 jrvs Initial Contribution
InitialContribution
1000 usd
CY2022Q4 us-gaap Variable Interest Entity Ownership Percentage
VariableInterestEntityOwnershipPercentage
0.50 pure
CY2022Q4 us-gaap Proceeds From Issuance Of Common Limited Partners Units
ProceedsFromIssuanceOfCommonLimitedPartnersUnits
1000 usd
CY2022Q4 us-gaap Cash Available For Distributions
CashAvailableForDistributions
5214000 usd
CY2023 us-gaap Investment Company Fee Paid Indirectly
InvestmentCompanyFeePaidIndirectly
2679500 usd
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001556801
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--07-31
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
586686 shares
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-07-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-55233
CY2023 dei Entity Registrant Name
EntityRegistrantName
My City Builders, Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-3816969
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
100 Biscayne Blvd.
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
#1611
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Miami
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33132
CY2023 dei City Area Code
CityAreaCode
786
CY2023 dei Local Phone Number
LocalPhoneNumber
553-4006
CY2023 dei Security12g Title
Security12gTitle
Common stock, par value $0.001 per share
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Public Float
EntityPublicFloat
429646 usd
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
586686 shares
CY2023 dei Auditor Firm
AuditorFirmId
2851
CY2023 dei Auditor Name
AuditorName
KCCW Accountancy Corp
CY2023 dei Auditor Location
AuditorLocation
Diamond Bar, California
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
151718 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
718 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
34858 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
0 usd
CY2023Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
228570 usd
CY2022Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
336480 usd
CY2023Q3 us-gaap Interest Receivable
InterestReceivable
3116 usd
CY2022Q3 us-gaap Interest Receivable
InterestReceivable
0 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
418262 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
337198 usd
CY2023Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
884276 usd
CY2022Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
0 usd
CY2023Q3 us-gaap Investments
Investments
947500 usd
CY2022Q3 us-gaap Investments
Investments
0 usd
CY2023Q3 us-gaap Assets
Assets
2250038 usd
CY2022Q3 us-gaap Assets
Assets
337198 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
237888 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
13075 usd
CY2023Q3 us-gaap Deferred Income Current
DeferredIncomeCurrent
0 usd
CY2022Q3 us-gaap Deferred Income Current
DeferredIncomeCurrent
6748 usd
CY2023Q3 jrvs Due To Related Party Current
DueToRelatedPartyCurrent
3726222 usd
CY2022Q3 jrvs Due To Related Party Current
DueToRelatedPartyCurrent
8812 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3964110 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
28635 usd
CY2023Q3 us-gaap Liabilities
Liabilities
3964110 usd
CY2022Q3 us-gaap Liabilities
Liabilities
28635 usd
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
100 usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
100 usd
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
586686 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
595986 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
587 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
596 usd
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
331114 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
331105 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2045818 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-23238 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1714017 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
308563 usd
CY2023Q3 us-gaap Minority Interest
MinorityInterest
-55 usd
CY2022Q3 us-gaap Minority Interest
MinorityInterest
0 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1714072 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
308563 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2250038 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
337198 usd
CY2023 us-gaap Interest Income Operating
InterestIncomeOperating
49187 usd
CY2022Q3 us-gaap Interest Income Operating
InterestIncomeOperating
1106 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24531 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
59 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
177931 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
24285 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
202462 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
24344 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-153275 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-23238 usd
CY2023 us-gaap Impairment Of Investments
ImpairmentOfInvestments
-1732000 usd
CY2022Q3 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0 usd
CY2023 jrvs Interest Expenses Related Party
InterestExpensesRelatedParty
137360 usd
CY2022Q3 jrvs Interest Expenses Related Party
InterestExpensesRelatedParty
0 usd
CY2023 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1869360 usd
CY2022Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2022635 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23238 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-2022635 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-23238 usd
CY2023 us-gaap Income Loss Attributable To Noncontrolling Interest
IncomeLossAttributableToNoncontrollingInterest
-55 usd
CY2022Q3 us-gaap Income Loss Attributable To Noncontrolling Interest
IncomeLossAttributableToNoncontrollingInterest
0 usd
CY2023 jrvs Net Loss Attributable To Stockholders Of My City Builders Inc
NetLossAttributableToStockholdersOfMyCityBuildersInc
-2022580 usd
CY2022Q3 jrvs Net Loss Attributable To Stockholders Of My City Builders Inc
NetLossAttributableToStockholdersOfMyCityBuildersInc
-23238 usd
CY2023 jrvs Basic And Diluted Loss Per Share Of Common Stock
BasicAndDilutedLossPerShareOfCommonStock
-3.41
CY2022Q3 jrvs Basic And Diluted Loss Per Share Of Common Stock
BasicAndDilutedLossPerShareOfCommonStock
-0.10
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
592744 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228093 shares
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
0 usd
CY2022Q3 jrvs Series A Preferred Stock Issued To Founders Amount
SeriesAPreferredStockIssuedToFoundersAmount
500000 usd
CY2022Q3 jrvs Reorganization Amount
ReorganizationAmount
-168199 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
308563 usd
CY2023 jrvs Common Stock Cancelled Amount
CommonStockCancelledAmount
0 usd
CY2023 jrvs Reverse Stock Split Adjustment Amount
ReverseStockSplitAdjustmentAmount
0 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-2022635 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1714072 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-2022635 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-23238 usd
CY2023 us-gaap Other Noncash Income
OtherNoncashIncome
0 usd
CY2022Q3 us-gaap Other Noncash Income
OtherNoncashIncome
1106 usd
CY2023 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
1732000 usd
CY2022Q3 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
34858 usd
CY2022Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
0 usd
CY2023 us-gaap Interest And Other Income
InterestAndOtherIncome
3116 usd
CY2022Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
0 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
39309 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8850 usd
CY2023 us-gaap Increase Decrease In Loans Deferred Income
IncreaseDecreaseInLoansDeferredIncome
6748 usd
CY2022Q3 us-gaap Increase Decrease In Loans Deferred Income
IncreaseDecreaseInLoansDeferredIncome
0 usd
CY2023 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
38710 usd
CY2022Q3 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
5825 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-257338 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9669 usd
CY2023 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
0 usd
CY2022Q3 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
335 usd
CY2023 jrvs Payments To Acquire Investment
PaymentsToAcquireInvestment
-2679500 usd
CY2022Q3 jrvs Payments To Acquire Investment
PaymentsToAcquireInvestment
0 usd
CY2023 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
179310 usd
CY2022Q3 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
328626 usd
CY2023 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
287220 usd
CY2022Q3 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
0 usd
CY2023 jrvs Proceed From Loan Recivable
ProceedFromLoanRecivable
185504 usd
CY2022Q3 jrvs Proceed From Loan Recivable
ProceedFromLoanRecivable
0 usd
CY2023 us-gaap Payments For Construction In Process
PaymentsForConstructionInProcess
884276 usd
CY2022Q3 us-gaap Payments For Construction In Process
PaymentsForConstructionInProcess
0 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3270362 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-328291 usd
CY2023 us-gaap Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants
ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants
0 usd
CY2022Q3 us-gaap Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants
ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants
500000 usd
CY2023 us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
5052300 usd
CY2022Q3 us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
0 usd
CY2023 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-1373600 usd
CY2022Q3 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-161322 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3678700 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
338678 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
151000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
718 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
718 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
151718 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
718 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
137360 usd
CY2022Q3 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023 jrvs Common Stock Cancelled
CommonStockCancelled
10 usd
CY2022Q3 jrvs Common Stock Cancelled
CommonStockCancelled
0 usd
CY2023 jrvs Reverse Stock Split Adjustment
ReverseStockSplitAdjustment
1 usd
CY2022Q3 jrvs Reverse Stock Split Adjustment
ReverseStockSplitAdjustment
0 usd
CY2023 us-gaap Nature Of Operations
NatureOfOperations
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>NOTE 1 - ORGANIZATION AND BUSINESS OPERATIONS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">My City Builders, Inc. (the “Company” or “My City Builders”) is a Nevada corporation incorporated on October 26, 2010 under the name Oconn Industries Corp. The Company’s name was changed on March 11, 2014 from Oconn Industries Corp. to Diamante Minerals, Inc., and to iMine Corporation on March 20, 2018 and to My City Builders, Inc on January 31, 2023.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">In July 2022, the Company acquired RAC Real Estate Acquisition Corp, a Wyoming Corporation ("RAC"). RAC is now a wholly owned subsidiary of the Company. The Company, through RAC, plans to focus on real estate transactions, in which the Company will buy and develop real estate for sale or rent of low-income housing. The Company plans to invest in three sectors of this market by (i) buying, refurbishing and selling traditional foreclosures, (ii) buying, developing and renting “Land Banks” that have an average pool of homes or lots in excess of 100 in one location and (iii) buying, refurbishing or developing and selling homes made available by the government through HECM pools. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 27, 2023, RAC, a wholly owned subsidiary of the Company entered into a Limited Liability Company Agreement dated effective March 27, 2023, (the “Agreement”) with, Frank Gillen, an individual (“Mr. Gillen”) and Michael Colvard, an individual (“Mr. Colvard”).</p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As a result of the Agreement, RAC, Mr. Gillen and Mr. Colvard formed a limited liability company called RAC Gadsden, LLC (“Gadsden”) incorporated in the state of Alabama. Gadsden will continue until terminated pursuant to the Agreement or as provided for under the laws of Alabama. The purpose of Gadsden is to purchase, finance, collateralize, improve, rehabilitate, market, sell or lease property. Gadsden has three members, RAC, Mr. Gillen and Mr. Colvard with an initial contribution of $98, $1 and $1, respectively, in exchange for a membership interest of 98%, 1%, and 1%, respectively. Each member is entitled to vote in accordance with their respective membership interest. Gadsden is a member managed LLC. On May 5, 2023 Mr. Colvard transferred his 1% and withdrew as a member of Gadsden.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Share Exchange and Reorganization</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On July 1, 2022, the Company entered into an Agreement and Plan of Reorganization dated June 30, 2022 with RAC, and the shareholders of RAC, namely Frank Gillen, Francis Pittilloni, and Yolanda Goodell (the “Shareholders”), whereby the Company issued to the Shareholders a combined 100,000 shares of Series A Preferred Stock, par value of $0.001 per share in consideration for a combined 1,000 shares of RAC common stock, par value $0.001, held by the Shareholders, which represents 100% of the issued and outstanding capital stock of RAC. As a result, RAC becomes a wholly owned subsidiary of the Company. Shareholders of RAC paid a combined capital contribution of $500,000 in cash as consideration for their combined 1,000 shares of RAC common stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong><em>Recapitalization</em></strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">For financial accounting purposes, this transaction was treated as a reverse acquisition by RAC and resulted in a recapitalization with RAC being the accounting acquirer and the Company as the acquired company. The consummation of this reverse acquisition resulted in a change of control. Accordingly, the historical financial statements prior to the acquisition are those of the accounting acquirer, RAC, and have been prepared to give retroactive effect to the reverse acquisition completed on June 30,2022 and represent the operations of RAC. The consolidated financial statements after the acquisition date, June 30, 2022, include the balance sheets of both companies at fair value, the historical results of RAC and the results of the Company from the acquisition date. All share and per share information in the accompanying consolidated financial statements and footnotes has been retroactively restated to reflect the recapitalization.</p>
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s periodic filings with the SEC include, where applicable, disclosures of estimates, assumptions, uncertainties and markets that could affect the financial statements and future operations of the Company.</p>
CY2023Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash and related party payables it will likely incur in the near future. The Company places its cash with financial institutions of high credit worthiness. At times, its cash balance with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it extends funds, and as such, it believes that any associated credit risk exposures are limited.</p>
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000 shares
CY2023 us-gaap Profit Loss
ProfitLoss
-2022635 usd
CY2023Q3 jrvs Retained Earning Accumulated Deficit
RetainedEarningAccumulatedDeficit
-2045818 usd
CY2022Q3 jrvs Promissory Note Principal Amount
PromissoryNotePrincipalAmount
672960 usd
CY2023 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.12 pure
CY2022Q3 us-gaap Notes Payable
NotesPayable
672960 usd
CY2023 jrvs Consideration For Notes Paid By Company
ConsiderationForNotesPaidByCompany
328626 usd
CY2023 jrvs Consideration For Notes Paid By Third Party Investor
ConsiderationForNotesPaidByThirdPartyInvestor
328626 usd
CY2022Q3 jrvs Promissory Note Principal Amount
PromissoryNotePrincipalAmount
358620 usd
CY2022Q3 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.12 pure
CY2022Q3 us-gaap Notes Payable
NotesPayable
358620 usd
CY2022Q3 jrvs Consideration For Notes Paid By Company
ConsiderationForNotesPaidByCompany
175007 usd
CY2022Q3 jrvs Consideration For Notes Paid By Third Party Investor
ConsiderationForNotesPaidByThirdPartyInvestor
175007 usd
CY2023 jrvs Company Collected On Principal Amount
CompanyCollectedOnPrincipalAmount
444325 usd
CY2023 jrvs Interest Income Of Collected Principal Amount
InterestIncomeOfCollectedPrincipalAmount
67457 usd
CY2023 us-gaap Proceeds From Collection Of Longterm Loans To Related Parties
ProceedsFromCollectionOfLongtermLoansToRelatedParties
157105 usd
CY2023 jrvs Interest Income Of Collected On Behalf Of Third Party Investor
InterestIncomeOfCollectedOnBehalfOfThirdPartyInvestor
28398 usd
CY2023 us-gaap Interest Income Operating
InterestIncomeOperating
49187 usd
CY2022 us-gaap Interest Income Operating
InterestIncomeOperating
1106 usd
CY2023Q3 jrvs Construction In Progress Of Cost
ConstructionInProgressOfCost
333596 usd
CY2023 us-gaap Lease Income
LeaseIncome
1250 usd
CY2022Q4 jrvs Sale Of Each Property By The Llc Company Receive Average Additional Cash Capital Contribution
SaleOfEachPropertyByTheLlcCompanyReceiveAverageAdditionalCashCapitalContribution
13000 usd
CY2023 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
1732000 usd
CY2023 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
38710 usd
CY2022 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
5825 usd
CY2023 us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
2670300 usd
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
595986 shares
CY2023Q3 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
700 shares
CY2023Q3 jrvs Common Stock Returned By Shareholders
CommonStockReturnedByShareholders
10000 shares
CY2023Q3 us-gaap Shares Held In Employee Stock Option Plan Committed To Be Released
SharesHeldInEmployeeStockOptionPlanCommittedToBeReleased
10000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
586686 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
595986 shares
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-2022635 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-23238 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-424753 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-4880 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
424753 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
4880 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
429633 usd
CY2022Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
4880 usd
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
429633 usd
CY2022Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4880 usd
CY2023Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2022Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd

Files In Submission

Name View Source Status
0001640334-23-002133-index-headers.html Edgar Link pending
0001640334-23-002133-index.html Edgar Link pending
0001640334-23-002133.txt Edgar Link pending
0001640334-23-002133-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
jrvs-20230731.xsd Edgar Link pending
jrvs_10k.htm Edgar Link pending
jrvs_ex311.htm Edgar Link pending
jrvs_ex321.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
jrvs-20230731_lab.xml Edgar Link unprocessable
jrvs-20230731_pre.xml Edgar Link unprocessable
jrvs_10k_htm.xml Edgar Link completed
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
jrvs-20230731_cal.xml Edgar Link unprocessable
jrvs-20230731_def.xml Edgar Link unprocessable